Skip to main content
Premium Trial:

Request an Annual Quote

Celera Diagnostics Revenues up, Losses Down in Q3 of FY2004

NEW YORK, April 27 (GenomeWeb News) - Celera Diagnostics reported increased revenues and smaller losses for the fiscal year 2004 third quarter today.

 

The company, a joint venture of Applied Biosystems and Celera Genomics, both units of Applera, had revenues of $7.5 million, up from $4.3 million during the same quarter last year.

 

R&D spending was $10.7 million, down from $11.7 million during the year-ago period.

 

Celera Diagnostics' net loss for the quarter decreased to $11.9 million, from $12.6 million during the same period last year.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.